A Trial of SHR-1905 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

November 12, 2022

Study Completion Date

November 12, 2022

Conditions

Asthma

Interventions

DRUG

SHR-1905

SHR-1905 will be injected subcutaneously

DRUG

Placebo

Placebo will be injected subcutaneously

Trial Locations (1)

Nucleus Network, Brisbane

All Listed Sponsors

lead

Atridia Pty Ltd.

INDUSTRY

NCT04800263 - A Trial of SHR-1905 in Healthy Subjects | Biotech Hunter | Biotech Hunter